1 May 2020 – Policy Brief
The evaluation of the risk of hospital and ICU admission, as well as the mortality associated with the COVID-19 is an important tool to plan the necessary resources to manage and care for patients, and to evaluate the consequences of the disease. Knowing associated risk factors will enable better care for patients, including advice regarding specific drugs either associated or as important not associated with an increased risk for mortality. Despite a high number of infected patients around the world, and many published data, the quality of these publications is generally low, with a risk of bias and confounding factors. Even though this should therefore be interpreted with great caution, and regularly evaluated, older age and cardiovascular and pulmonary comorbidities are associated with a higher risk of severe disease.